Tsingke Gene Factory is at the heart of Tsingke Biotech’s strategic vision, offering a fully integrated platform for DNA/RNA synthesis. Our mission, "Biotech for a Better World," drives us to empower global scientific discovery and biopharmaceutical innovation.
With expertise in Gene Reading, Writing, and Editing, we have built an independent R&D ecosystem that covers the entire value chain—from raw material production and instrument manufacturing to advanced synthesis workflows. This comprehensive ecosystem enables us to provide end-to-end solutions, spanning from raw materials to sequencing.
Our AI-powered platform further enhances this ecosystem by incorporating high-throughput oligonucleotide manufacturing, antibody discovery and production, as well as strain engineering and screening. With in-house reagents, self-developed synthesizers, and automation systems, the factory is built for scalability, speed, and precision.
Capable of supporting production from microgram-level to industrial scale, we ensure the high quality standards across biopharmaceuticals, agriculture, and other industries worldwide.
End-to-End Integration
Raw Material Production: DNA/RNA phosphoramidites, solid supports, and synthesis reagents produced in-house.
Instrument Development: Proprietary oligo synthesizers (12P, 192B, 768B), purifiers, and automation platforms.
Manufacturing Workflow: AI-driven production management system (Tsingke HelixTech) enabling real-time tracking, quality control, and lean manufacturing.
Synthesis Excellence
Gene Synthesis: Up to 200 kb in length with 160+ ready-to-use vectors, free codon optimization, and cloning services.
Oligo & Modified Nucleic Acids: Over 200 modification types, multiple purification options, and support for research, diagnostics, and therapeutics.
RNA Synthesis: mRNA, saRNA, circRNA with LNP formulation services.
Protein & Antibody Services: From gene to protein expression and purification.
Quality and Compliance
Facilities: 12,000 m² R&D center and 100,000-class cleanroom manufacturing space.
Certifications: ISO 9001, ISO 13485, and GMP-compliant production lines.
Validation: Full NGS verification, QC traceability, and strict SOP management.
From monomers to final product, all in-house for maximum quality control.
Streamlined workflows for faster turnaround and fewer errors.
From research-scale to industrial GMP batches.
Trusted by 300,000+ researchers worldwide.
Serving academia, diagnostics, and biotech companies across 100+ countries.
Founder began entrepreneurial activities in nucleic acid synthesis
Founder began entrepreneurial activities in nucleic acid synthesis
Expanded into chemical raw material production
Expanded into chemical raw material production
Launched professional genetic testing services
Launched professional genetic testing services
Introduced oligonucleotide synthesis and advanced modification capabilities
Introduced oligonucleotide synthesis and advanced modification capabilities
Developed proprietary automated synthesis instruments
Developed proprietary automated synthesis instruments
Expanded operations to molecular reagent production
Expanded operations to molecular reagent production
Incorporated as Beijing Tsingke Biotech Co., Ltd., focusing on gene synthesis services
Incorporated as Beijing Tsingke Biotech Co., Ltd., focusing on gene synthesis services
Secured 150 M CNY Series A funding and entered the protein antibody market
Secured 150 M CNY Series A funding and entered the protein antibody market
Secured 400 M CNY Series B funding and initiated R&D in gene regulation and small nucleic acid therapeutics
Secured 400 M CNY Series B funding and initiated R&D in gene regulation and small nucleic acid therapeutics
Completed joint-stock transformation as Beijing Tsingke Biotech Joint-stock Co., Ltd
Completed joint-stock transformation as Beijing Tsingke Biotech Joint-stock Co., Ltd
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
